SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease

Publication date: Available online 13 April 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Katherine R Tuttle

Source: The Lancet Diabetes and Endocrinology - April 13, 2019 Category: Endocrinology Source Type: research